Business Context and Reporting Period
This Form 8-K filing by NAYA Biosciences, Inc. (not INVO Fertility, Inc.) covers events occurring between September 18, 2024, and March 31, 2025. The report addresses a critical listing compliance issue with The Nasdaq Stock Market LLC regarding the company's common stock (Trading Symbol: NAYA).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and stock listing status rather than financial performance metrics.
Material Changes
- Listing Deficiency: On September 18, 2024, Nasdaq notified the company of failure to maintain a minimum closing bid price of $1.00 per share for 34 consecutive days.
- Reverse Stock Split: On March 18, 2025, the company executed a 1-for-12 reverse stock split to address the deficiency.
- Delisting Notice: On March 25, 2025, Nasdaq initially determined the company should be delisted because compliance was not evidenced by the March 17, 2025 deadline.
- Compliance Regained: As of March 31, 2025, the company evidenced a closing bid price of at least $1.00 per share for 10 consecutive business days, resulting in the closure of the delisting matter.
Outlook, Risks, and Management Commentary
The primary risk addressed was the potential delisting from Nasdaq due to low stock price. Management's commentary is limited to the factual timeline of the reverse split and the subsequent restoration of compliance. No forward-looking guidance, financial outlook, or discussion of other contingencies is provided in this filing.
Investor Verification Checklist
- Verify the current trading status of NAYA Biosciences on Nasdaq to confirm the listing remains active post-March 31, 2025.
- Confirm the adjusted share count and price following the 1-for-12 reverse stock split.
- Review subsequent filings to ensure the company maintains the $1.00 minimum bid price to avoid future delisting notices.
- Note the discrepancy between the requested company name (INVO Fertility) and the actual registrant (NAYA Biosciences).